EPIDAREX CAPITAL MANAGEMENT LLC
EPIDAREX CAPITAL MANAGEMENT LLC is a Seed and Series A fund in the US and UK writing $100K–$30M checks into Healthcare, biotechnology, pharmaceuticals and medical-devices.
- Stages
- Seed, Series A
- Sectors
- Healthcare, biotechnology, pharmaceuticals, medical-devices
- Check size
- $100K–$30M
- Invests in
- US-wide, UK
- Round role
- Leads rounds
- Actively investing
- Yes
- Founded
- 2010
- Assets under management
- $395M
Thesis
Epidarex Capital Management LLC is a transatlantic venture capital firm that invests in early-stage life science and health technology companies. Their strategy focuses on identifying and funding transformative opportunities in emerging and under-ventured research hubs within the United States and the United Kingdom, often partnering with universities and research institutions. They specialize in biotechnology, pharmaceuticals, medical devices, and health technology, seeking disruptive platform technologies that address significant unmet medical needs with strong intellectual property and market validation. The firm has raised multiple funds, with total assets under management reaching approximately $395 million. Their third fund closed at $126.3 million in 2020, and their fourth fund, Epidarex Capital IV, LP, secured over $145 million in commitments and is expected to invest in up to 15 companies.
Common questions
Does EPIDAREX CAPITAL MANAGEMENT LLC invest at the Seed stage?
Yes. EPIDAREX CAPITAL MANAGEMENT LLC lists Seed and Series A among the stages it invests in.
What check size does EPIDAREX CAPITAL MANAGEMENT LLC write?
EPIDAREX CAPITAL MANAGEMENT LLC writes $100K–$30M checks.
Where does EPIDAREX CAPITAL MANAGEMENT LLC invest?
EPIDAREX CAPITAL MANAGEMENT LLC invests in the US and UK.